[go: up one dir, main page]

ES2012119A6 - Procedimiento para la produccion de supositorios a base de calcitoninas. - Google Patents

Procedimiento para la produccion de supositorios a base de calcitoninas.

Info

Publication number
ES2012119A6
ES2012119A6 ES8802832A ES8802832A ES2012119A6 ES 2012119 A6 ES2012119 A6 ES 2012119A6 ES 8802832 A ES8802832 A ES 8802832A ES 8802832 A ES8802832 A ES 8802832A ES 2012119 A6 ES2012119 A6 ES 2012119A6
Authority
ES
Spain
Prior art keywords
suppositories
calcitonin
procedure
production
suppository
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8802832A
Other languages
English (en)
Inventor
Moise Azria
Michel Steiger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721700A external-priority patent/GB8721700D0/en
Priority claimed from GB888801991A external-priority patent/GB8801991D0/en
Priority claimed from GB888805068A external-priority patent/GB8805068D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2012119A6 publication Critical patent/ES2012119A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Epoxy Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE SUPOSITORIOS A BASE DE CALCITONINAS, CUYOS SUPOSITORIOS INCLUYEN CONCRETAMENTE UNA BASE DE SUPOSITORIO, UNA CALCITONINA Y ACIDO TARROCOLICO O UNA SAL DE ESTE FARMACEUTICAMENTE ACEPTABLE, CARACTERIZADO PORQUE COMPRENDE MEZCLAR LA CALCITONINA CON PREFERIBLEMENTE 1,8 A 4% EN PESO, RESPECTO AL PESO DE LA MASA DEL SUPOSITORIO DE ACIDO TAUROCOLICO O UNA SAL DE ESTE, Y CON LA BASE DE SUPOSITORIO, AÑADIENDO PREFERIBLEMENTE UN AGENTE TAMPON PARA PROPORCIONAR UN PH DE 3,8 A 5, Y AÑADIENDO TAMBIEN PREFERIBLEMENTE UN DILUYENTE SOLUBLE EN AGUA, CON PREFERENCIA A TEMPERATURAS POR DEBAJO DE 40GC; Y CONVERTIR LA MEZCLA RESULTANTE EN SUPOSITORIOS, PREFERIBLEMENTE A TEMPERATURAS TAMBIEN INFERIORES A 40GC.
ES8802832A 1987-09-15 1988-09-15 Procedimiento para la produccion de supositorios a base de calcitoninas. Expired - Lifetime ES2012119A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878721700A GB8721700D0 (en) 1987-09-15 1987-09-15 Organic compounds
GB888801991A GB8801991D0 (en) 1988-01-29 1988-01-29 Improvements in/relating to organic compounds
GB888805068A GB8805068D0 (en) 1988-03-03 1988-03-03 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
ES2012119A6 true ES2012119A6 (es) 1990-03-01

Family

ID=27263605

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802832A Expired - Lifetime ES2012119A6 (es) 1987-09-15 1988-09-15 Procedimiento para la produccion de supositorios a base de calcitoninas.

Country Status (26)

Country Link
US (1) US5149537A (es)
JP (1) JPH01228919A (es)
KR (1) KR970003052B1 (es)
AT (1) AT396424B (es)
AU (1) AU614769B2 (es)
BE (1) BE1001937A3 (es)
CA (1) CA1330417C (es)
CH (1) CH677320A5 (es)
CY (1) CY1763A (es)
DE (1) DE3830245A1 (es)
DK (1) DK509888A (es)
ES (1) ES2012119A6 (es)
FI (1) FI87889C (es)
FR (1) FR2620331B1 (es)
GB (1) GB2209670B (es)
HK (1) HK19394A (es)
HU (1) HU203204B (es)
IL (1) IL87747A (es)
LU (1) LU87334A1 (es)
MY (1) MY103611A (es)
NL (1) NL8802274A (es)
NO (1) NO175518C (es)
NZ (1) NZ226162A (es)
PH (1) PH24766A (es)
PT (1) PT88491B (es)
SE (1) SE8803222L (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520983A4 (en) * 1990-03-15 1993-04-28 Rhone-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
ATE292956T1 (de) 1998-07-24 2005-04-15 Seo Hong Yoo Klare wässrige lösungen enthaltend gallensäuren
CN100558407C (zh) * 2000-02-04 2009-11-11 柳署弘 制备含有胆汁酸的澄清水溶液剂型
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
PL1651249T3 (pl) 2003-07-23 2013-04-30 Novartis Ag Zastosowanie kalcytoniny w zapaleniu kości i stawów
CN101035541B (zh) * 2004-08-30 2012-05-30 柳署弘 溶解的udca在局灶缺血模型中的神经保护作用
CN101039699B (zh) * 2004-10-15 2011-07-27 柳署弘 用于减小药物化合物毒性的方法和组合物
DE602005025391D1 (de) * 2004-11-01 2011-01-27 Seo Hong Yoo Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
KR102287352B1 (ko) * 2015-06-30 2021-08-06 (주)아모레퍼시픽 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH211204A (de) * 1938-12-13 1940-08-31 Chem Ind Basel Verfahren zur Herstellung einer Suppositoriengrundmasse.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
ATE8584T1 (de) * 1980-01-16 1984-08-15 Hans Georg Prof. Dr. Weder Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel.
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
EP0037943B1 (en) * 1980-03-31 1985-08-14 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
FR2620331A1 (fr) 1989-03-17
LU87334A1 (fr) 1989-07-07
AU2217588A (en) 1989-04-20
CA1330417C (en) 1994-06-28
SE8803222L (sv) 1989-03-16
DK509888A (da) 1989-03-16
ATA224788A (de) 1993-01-15
NZ226162A (en) 1991-03-26
BE1001937A3 (fr) 1990-04-17
FI884191L (fi) 1989-03-16
KR890004680A (ko) 1989-05-09
PH24766A (en) 1990-10-01
FI87889C (fi) 1993-03-10
KR970003052B1 (ko) 1997-03-14
HUT47864A (en) 1989-04-28
GB2209670B (en) 1991-05-08
US5149537A (en) 1992-09-22
DK509888D0 (da) 1988-09-13
NO175518B (no) 1994-07-18
CY1763A (en) 1994-07-15
CH677320A5 (es) 1991-05-15
HK19394A (en) 1994-03-18
FI884191A0 (fi) 1988-09-13
JPH01228919A (ja) 1989-09-12
GB8821429D0 (en) 1988-10-12
IL87747A0 (en) 1989-02-28
NO884053D0 (no) 1988-09-13
AU614769B2 (en) 1991-09-12
MY103611A (en) 1993-08-28
IL87747A (en) 1992-05-25
DE3830245A1 (de) 1989-03-30
HU203204B (en) 1991-06-28
GB2209670A (en) 1989-05-24
PT88491B (pt) 1992-11-30
FI87889B (fi) 1992-11-30
NO884053L (no) 1989-03-16
AT396424B (de) 1993-09-27
FR2620331B1 (fr) 1991-11-08
PT88491A (pt) 1988-10-01
NO175518C (no) 1994-10-26
SE8803222D0 (sv) 1988-09-13
NL8802274A (nl) 1989-04-03

Similar Documents

Publication Publication Date Title
ES2012119A6 (es) Procedimiento para la produccion de supositorios a base de calcitoninas.
ATE83927T1 (de) Thrombinzusammensetzung.
FR2633929B2 (fr) Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
AU1668283A (en) Sodium metasilicate
ES2171407T3 (es) Procedimiento de preparacion de polimeros injertados solubles en agua.
IT7928019A0 (it) Procedimento per la produzione d'acido metacrilico e catalizzatore in esso impiegato.
FI853456A0 (fi) Expektorant.
IT8220323A0 (it) Agente per ridurre la quantita' di acqua in un cemento riducendo anche la quantita' di aria.
IT8024827A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia.
IT1092150B (it) Procedimento per la produzione di oggetti di carbonio o grafite con elevata solidita'
SE8700137D0 (sv) Diuretisk komposition
ES8506548A1 (es) Un metodo de formacion de un producto de vidrio o ceramica
ES2008598A6 (es) Composicion limpiadora acuosa espesada reforzada sin fosfatos o con bajo contenido de fosfatos.
MY102526A (en) Liquid cleanser composition
AR246496A1 (es) Una composicion de aluminio-silicato de metal alcalino, metodo para obtenerla y articulo de fabricacion que contiene a dicha composicion.
BR8405277A (pt) Processo para manufatura de um po detergente
EP0315118A3 (en) Dna coding for endothelin and use thereof
ES8801082A1 (es) Procedimiento para la fabricacion de una cama para animales.
ES2015896B3 (es) Sal de una morfolina sustituida con acido fluoborico y agente para la proteccion de la madera.
DE3762121D1 (de) Alkalische gipsmischung mit guarderivaten.
ES8605533A1 (es) Procedimiento para la preparacion de esteres fosfato ciclicode 9-1,3-dihidroxi-2-propoximetil-guanina
SE8704240D0 (sv) Analgesic preparations
IT1196513B (it) Griglia antisdrucciolo per l'impiego in stalle,per esempio porcili,come pure barretta sagomata per produrre tale griglia antisdrucciolo
TR23253A (tr) Zorunlu olarak sodyum suelfat meydana gelmeden parafin-sulfoksidasyon-reaksiyon karisimlarindan alkali suelfat bakimindan fakir parafin suelfonot'larinin ve suelfuerik asidin izde edilmesine mahsus usul
DE3483318D1 (de) Lorazepam-haltiges schlafmittel.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-09-15

FD1A Patent lapsed

Effective date: 20001204